Alexei Navalny’s Death Is a Loss for Russia and the World U.S. Senator Marco Rubio (R-FL) February 21, 2024 Newsweek …For more than 10 years, [Alexei] Navalny openly opposed the Russian dictator, calling out the “crooks and thieves” in the Kremlin who enabled his...
After years of left-leaning governments, the people of Argentina democratically elected President Javier Milei and Vice President Victoria Villarruel. U.S. Senator Marco Rubio (R-FL), Vice Chairman of the Senate Select Committee on Intelligence, met with President...
Tras años de gobiernos de izquierda, el pueblo de Argentina democráticamente eligió al presidente Javier Milei y la vicepresidenta Victoria Villarruel. El senador estadounidense Marco Rubio (R-FL), vicepresidente del Comité Selecto de Inteligencia del Senado, se...
Families Deserve Better than Democrats’ Child “Tax Credit” U.S. Senator Marco Rubio (R-FL) February 20, 2024 National Review The child tax credit (CTC) has been a pillar of conservative, pro-family policy for almost 30 years…. But today, Republicans are poised to undo...
TikTok, a social media app controlled by the Chinese Communist Party, is a national security risk to the United States. Republicans and Democrats in Congress, the U.S. Department of Defense, the Federal Bureau of Investigation, and President Joe Biden’s White House...
On July 18, 1994, Iranian-backed Hezbollah mercenaries carried out a brutal terrorist attack against the Asociación Mutual Israelita Argentina (AMIA) Building in Buenos Aires. The hateful terrorist attack killed 85 and injured hundreds of civilians. U.S....
Senators Rubio, Gillibrand, Markey, and Gardner Introduce Bipartisan Legislation to Strengthen America’s Bioeconomy
The Bioeconomy Research and Development Act of 2020 Would Strengthen And Broaden Research In Engineering Biology As Scientists And Researchers Search For Vaccine Amidst Covid-19 Emergency
Washington, D.C. — U.S. Senators Marco Rubio (R-FL), Kirsten Gillibrand (D-NY), Cory Gardner (R-CO), and Ed Markey (D-MA) introduced bipartisan legislation to strengthen America’s bioeconomy. As scientists and researchers rush to develop a vaccine for COVID-19, the Bioeconomy Research and Development Act of 2020 would strengthen and broaden engineering biology by establishing an initiative to promote research and development, advance biomanufacturing, develop the future bioeconomy workforce, and establishes safeguards to ensure the research is secure and conducted ethically. The legislation would also establish a committee to coordinate all federal research in engineering biology across the federal agencies.
“The preservation of the American economy is reliant on cutting edge innovation, technology, and discovery,” Rubio said. “Amid the coronavirus pandemic, it is more important now than ever that we invest in engineering biology research to help scientists working to develop a vaccine, while also establishing a legal framework to safeguard the research. I am proud to join my colleagues in introducing this legislation to strengthen both our economy and our research capability.”
“Investing in engineering biology research is critical for our country, now and for our future,” Gillibrand said. “In addition to helping scientists develop a vaccine to protect Americans from coronavirus, engineering biology research touches everything from our food, to our environment, to our health care. Strengthening and coordinating our nation’s research initiatives will not only make us safer, but it will bolster our economy and put the United States at the forefront of global research leadership. I’m proud to lead this bipartisan bill in the Senate.”
“Biotechnology and life sciences innovation drives our bioeconomy, and this legislation will ensure that the United States remains a leader in engineering biology research and innovation, supporting the hundreds of thousands of workers in the health, energy, agriculture, and manufacturing sectors that contribute to this field. Massachusetts is more than the Bay State, we are the Brain State and our state’s bioeconomy is our lifeblood,” Markey said. “The coronavirus pandemic has shown us how important it is to coordinate science research and stay at the forefront of health technology, whether it is detecting new viruses or rapidly developing vaccines. This bill will enable us to better coordinate bioengineering research and ensure we remain a global leader.”
“Like the technological revolution and the Industrial Revolution before it, the biological revolution will reshape how we interact with and understand the world around us,” Gardner said. “I’m proud to work with my colleagues on both sides of the aisle to develop a stronger bioeconomy, which will lead to new scientific developments like improved vaccines and innovations in agriculture, food, medicine, clothing, and more.”
In addition to developing new vaccines and medical therapies, engineering biology research is used to develop nutritious, locally grown specialty crops that are resilient to climate change; to make food safer with technologies that detect harmful microorganisms and fight antimicrobial resistance; to help wounded service members regain quality of life with advanced prosthetics, burn treatments, and regenerative therapeutics; to develop low-cost lifesaving drugs and early detection of cancer; and to clean the environment by creating non-polluting batteries, preserved biodiversity, and microbes that can chew through persistent toxic chemicals. The bipartisan Bioeconomy Research and Development Act of 2020 would establish an initiative through the White House Office of Science and Technology Policy (OSTP) to strengthen and broaden the country’s research capacities. Additionally, while federal agencies — such as NSF, NIST, DoE, DoD, NASA, USDA, NIH, FDA, and EPA — are all independently investing in engineering biology research, the legislation would coordinate these efforts.
Specifically, the Bioeconomy Research and Development Act of 2020 would:
- Establish an Initiative through OSTP to advance research and development, advance biomanufacturing, develop the future bioeconomy workforce, and support research in ethical, legal, environmental, safety, security, and societal issues;
- Direct the National Academies to review ethical, legal, environmental, safety, security, and societal issues related to engineering biology; and
- Direct OSTP to lead an interagency coordination committee and define roles of participating agencies.
The legislation is endorsed by leading research institutes including the Biotechnology Innovation Organization (BIO), Cornell University’s Boyce Thompson Institute, the President of the Hastings Center for bioethics research, Johns Hopkins Center for Health Security, National Organization of Rare Disorders, the American Society for Microbiology, American Society of Mechanical Engineers, and SynBioBeta.